BST/1KJ (BST/1KJ)

Stuttgart Stock Exchange: BST/1KJ · EUR

€64.4

-0.74 (-1.1%)· Recorded snapshot

Market cap	9.1B
Revenue (ttm)	540M
Net income (ttm)	-65.8M
EPS (ttm)	-€0.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 540M
Net income (ttm): -65.8M
EPS (ttm): -€0.53
Market cap: 9.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-9.4

P25 n/aP50 n/aP75 n/a

ROIC-5.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BST/1KJ indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-05
Employees	1,178
Employees change	-128
Employees growth	-9.8%
Enterprise value	EUR 8.7B
Exchange	Stuttgart Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2012
Industry	Medical Devices
Is primary listing	No
ISIN number	US88025U1097
Last refreshed	2026-10-28
Market cap	EUR 9.1B
Next earnings date	2026-11-05
Price	EUR 64.35
Price currency	EUR
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-27
Symbol	bst/1KJ
Website	https://www.10xgenomics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.82%
EV/FCF	81.84x
EV/Sales	15.71x
FCF / EV yield	1.22%
FCF yield	1.17%
Industry forward P/E	17.57x
Industry P/E	20.35x
P/(FCF - SBC) ratio	459.27x
P/(OCF - SBC) ratio	367.74x
P/B ratio	12.63x
P/FCF ratio	85.83x
P/OCF ratio	82.02x
P/S ratio	16.9x
Price / tangible book value	13.76x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-13.16%
EBITDA margin	-6.68%
FCF margin	19.18%
Gross margin	70.11%
Operating margin	-13.16%
Pretax margin	-12.14%
Profit margin	-12.18%
Profit per employee	EUR -55,821
Revenue per employee	EUR 458,389
ROA	-5.05%
ROA (5Y)	-9.03%
ROCE	-8.91%
ROE	-9.4%
ROE (5Y)	-18.37%
ROIC	-5.75%
SBC / revenue	16.01%
Tax / revenue	0.04%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
FCF growth	113.51%
FCF growth (Q)	-4.61%
FCF growth (QoQ)	-37.26%
Gross profit growth	-3.36%
Gross profit growth (Q)	-10.06%
Gross profit growth 3Y	1.11%
Gross profit growth 5Y	4.3%
Net income growth years	2
OCF growth	89.82%
OCF growth (Q)	-4.15%
OCF growth (QoQ)	-35.02%
Revenue growth	-4.28%
Revenue growth (Q)	-12.65%
Revenue growth (QoQ)	0.13%
Revenue growth 3Y	2.77%
Revenue growth 5Y	8.74%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -4.9M
Depreciation and amortization	EUR 35.9M
EBIT	EUR -71.1M
EBITDA	EUR -36.1M
EPS	EUR -0.53
Financing cash flow	EUR -2.2M
Free cash flow	EUR 106.3M
Free cash flow minus SBC	EUR 19.9M
Gross profit	EUR 378.6M
Income taxes	EUR 205,696
Investing cash flow	EUR -17.2M
Net cash flow	EUR 91.7M
Net income	EUR -65.8M
Operating cash flow minus SBC	EUR 24.8M
Operating income	EUR -71.1M
Revenue	EUR 540M
Stock-based compensation	EUR 86.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.75
Book value per share	EUR 5.55
Debt / equity	0.1
Debt / FCF	0.65
Goodwill	EUR 6.2M
Long-term assets	EUR 295.7M
Long-term liabilities	EUR 72.6M
Net cash (debt)	EUR 414.2M
Net cash / market cap	4.54%
Net cash growth	31.27%
Net debt / equity	-0.57
Net debt / FCF	-3.9
Piotroski F-Score	3
Property, plant and equipment	EUR 244.3M
Shareholders' equity	EUR 722.6M
Tangible book value	EUR 663M
Tangible book value per share	EUR 5.09
Total assets	EUR 901.6M
Total cash	EUR 483.2M
Total debt	EUR 69M
Total liabilities	EUR 179M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	EUR 605.9M
Current liabilities	EUR 106.4M
Current ratio	5.69
Inventory turnover	3.03
Net working capital	EUR 14.1M
Quick ratio	5.09
Working capital	EUR 486.8M
Working capital turnover	0.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.39%
Shareholder yield	-4.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 40.44
1D price change	-1.14%
1M price change	-13.98%
1M total return	-13.98%
1W price change	3.13%
1W total return	3.13%
1Y price change	476.1%
1Y return CAGR	476.79%
1Y total return	476.1%
20-day SMA	EUR 68.92
200-day SMA	EUR 34.59
3M price change	57.74%
3M total return	57.74%
3Y price change	42.18%
3Y return CAGR	12.44%
3Y total return	42.18%
50-day SMA	EUR 63.80
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 89.95
52-week high date	2026-10-06
52-week low	EUR 11.46
52-week low date	2025-11-05
5Y price change	-51.85%
5Y return CAGR	-13.6%
5Y total return	-51.85%
6M price change	244.52%
6M total return	244.52%
All-time high	EUR 171.55
All-time high date	2021-04-27
All-time low	EUR 6.51
All-time low date	2025-04-07
Average true range (ATR)	EUR 4.15
Average volume	149.7
Change from 52-week high	-28.46%
Change from 52-week low	461.76%
Change from all-time high	-62.49%
Change from all-time low	888.18%
Change from open	-1.29%
Day's gap	0.15%
High price	EUR 65.91
Low price	EUR 64.35
Monthly RSI	66.16
Open price	EUR 65.19
Position in 52-week range	0%
Previous close	EUR 65.09
Price vs 150-day SMA	59.11%
Price vs 20-day SMA	-6.63%
Price vs 200-day SMA	86.04%
Price vs 50-day SMA	0.86%
Relative volume	0.98
RSI	47.46
Sharpe ratio	1.99
Sortino ratio	3.6
Weekly RSI	63.4
YTD price change	379.33%
YTD total return	379.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	118.2M
Shares change (QoQ)	1.32%
Shares change (YoY)	4.39%
Shares held by insiders	7.79%
Shares held by institutions	101.4%
Short ratio	3.8 days

Deeper analysis on BST/1KJ

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BST/1KJ report

Is a complete BST/1KJ research report available?

No complete published report is available for bst/1KJ (BST/1KJ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/1KJ (BST/1KJ)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/1KJ

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BST/1KJ indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/1KJ

Frequently asked questions